Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients

NCT03205267 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
127
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Bonn

Collaborators